/Companies

Axsome Therapeutics

NASDAQ: AXSM

New York, US · Founded 2012 · Delaware corporation

Find your way into Axsome Therapeutics

193 people in our graph share verified history with the Axsome Therapeutics team — schools, employers, funds. One of them is your warm intro.

Justin Robenyunlockedknows Herriot Tabuteau · together at Axsome Therapeutics (overlapped)
×3knows the team · via Axsome Therapeutics
×8knows the team · via Wesleyan University

Axsome Therapeutics is a biopharmaceutical company. The available page content is only an external-link disclaimer and does not describe the company's products or activities in detail.

Founders & leadership

Axsome Therapeutics was founded in 2012 by Herriot Tabuteau.

HT
Herriot TabuteauFounder · Chief Executive OfficerHerriot Tabuteau is an executive officer and director at Axsome Therapeutics, a biopharmaceutical company developing therapies for pain and neurological disorders.
NPNick Pizzie
Nick PizzieChief Financial Officer
MJMark Jacobson
Mark JacobsonChief Operating Officer
AM
Ari MaizelChief Commercial Officer

Reported raises · per SEC filings

Form D private placements

$5.8M disclosed across 3 rounds · 2014–2015

▶$2.5MraisedMay 2015 · 14 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Herriot TabuteauExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$2.5M
Minimum investment
$25K
First sale
May 2015
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$1.3MraisedJan 2015 · 4 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Herriot TabuteauExecutive Officer, Director
Offering amount
$2M
Amount sold
$1.3M
Minimum investment
$25K
First sale
Dec 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$2MraisedSep 2014 · 12 investors · Pharmaceuticals
Rule 506(b)
Officers, directors & promoters on the filing
  • Herriot TabuteauExecutive Officer, Director
Offering amount
$7.5M
Amount sold
$2M
Minimum investment
$25K
Sales commissions
$500K
Placement agents
Brookline Group, LLC
First sale
Sep 2014
Incorporated
Corporation, Delaware, 2012
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Valuation · disclosed

Disclosed events
$172.2Mvaluation at IPONov 2015 · $9.00/share · 424B4
filing ↗

Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.

Founder mafia

2 people who came through Axsome Therapeutics went on to found or lead other companies.

Competitors · 2

by search overlap

Companies competing with Axsome Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Axsome Therapeutics do?
Axsome Therapeutics is a biopharmaceutical company. The available page content is only an external-link disclaimer and does not describe the company's products or activities in detail.
Who founded Axsome Therapeutics?
Axsome Therapeutics was founded by Herriot Tabuteau in 2012.
How much funding has Axsome Therapeutics raised?
Axsome Therapeutics has disclosed $5.8M raised across 3 rounds.
Where is Axsome Therapeutics headquartered?
Axsome Therapeutics is headquartered in New York, US.